[HTML][HTML] Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021

Q Wu, W Qian, X Sun, S Jiang - Journal of hematology & oncology, 2022 - Springer
Abstract The United States Food and Drug Administration (US FDA) has always been a
forerunner in drug evaluation and supervision. Over the past 31 years, 1050 drugs …

Immunomodulatory biomaterials against bacterial infections: Progress, challenges, and future perspectives

S Zhang, H Yang, M Wang, D Mantovani, K Yang… - The Innovation, 2023 - cell.com
Bacterial infectious diseases are one of the leading causes of death worldwide. Even with
the use of multiple antibiotic treatment strategies, 4.95 million people died from drug …

A human urothelial microtissue model reveals shared colonization and survival strategies between uropathogens and commensals

C Flores, J Ling, A Loh, RG Maset, A Aw, IJ White… - Science …, 2023 - science.org
Urinary tract infection is among the most common infections worldwide, typically studied in
animals and cell lines with limited uropathogenic strains. Here, we assessed diverse …

[HTML][HTML] TcpC inhibits M1 but promotes M2 macrophage polarization via regulation of the MAPK/NF-κB and Akt/STAT6 pathways in urinary tract infection

J Fang, Q Ou, B Wu, S Li, M Wu, J Qiu, N Cen, K Hu… - Cells, 2022 - mdpi.com
TcpC is a multifunctional virulence factor of Uropathogenic Escherichia coli (UPEC).
Macrophages can differentiate into two different subsets M1 and M2 that play distinct roles in …

[HTML][HTML] Complicated urinary tract infections

A Sabih, SW Leslie - 2017 - europepmc.org
Complicated Urinary Tract Infections - Abstract - Europe PMC Sign in | Create an account
https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …

[HTML][HTML] SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF …

M Tutone, TEB Johansen, T Cai, S Mushtaq… - International Journal of …, 2022 - Elsevier
Urinary tract infections (UTIs) are prevalent worldwide, particularly among women. Their
incidence increases with age, and treatment is increasingly challenging owing to antibiotic …

Cross-roads for meta-analysis and network meta-analysis of H. pylori therapy

DY Graham, R Hernaez, T Rokkas - Gut, 2022 - gut.bmj.com
Helicobacter pylori infections are responsible for tremendous morbidity and mortality
worldwide, leading to efforts to eradicate the organism. However, the effectiveness of …

[HTML][HTML] A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance

F Wagenlehner, L Nicolle, R Bartoletti, AC Gales… - Journal of global …, 2022 - Elsevier
Objectives Uncomplicated urinary tract infections (uUTIs) are a common problem in female
patients. Management is mainly based on empirical prescribing, but there are concerns …

[HTML][HTML] Phage therapy related microbial succession associated with successful clinical outcome for a recurrent urinary tract infection

A Terwilliger, J Clark, M Karris, H Hernandez-Santos… - Viruses, 2021 - mdpi.com
We rationally designed a bacteriophage cocktail to treat a 56-year-old male liver transplant
patient with complex, recurrent prostate and urinary tract infections caused by an extended …

[HTML][HTML] Antimicrobial resistance of clinical Enterobacterales isolates from urine samples, Germany, 2016 to 2021

C Stoltidis-Claus, KD Rosenberger… - …, 2023 - eurosurveillance.org
Introduction Empirical therapy for the treatment of urinary tract infections should be tailored
to the current distribution and susceptibility of potential pathogens to ensure optimal …